Enliven Therapeutics Inc Share Price Today: Live Updates & Key Insights
Enliven Therapeutics Inc share price today is $28.96, up -3.39%. The stock opened at $29.93 against the previous close of $30.05, with an intraday high of $30.02 and low of $28.655.
Enliven Therapeutics Inc Share Price Chart
Enliven Therapeutics Inc
Enliven Therapeutics Inc Share Price Performance
Enliven Therapeutics Inc Institutional Holdings
Enliven Therapeutics Inc Market Status
Enliven Therapeutics Inc Fundamentals
Market Cap 1736.01 M
PB Ratio 3.9099
PE Ratio 0.0
Enterprise Value 1273.78 M
Total Assets 476.17 M
Volume 862701
Enliven Therapeutics Inc Company Financials
About Enliven Therapeutics Inc & investment objective
Company Information Enliven Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of small molecule inhibitors to help patients with cancer. Its clinical programs comprise ELVN-001, a small molecule kinase inhibitor which is in Phase 1 clinical trial to treat adults with chronic myeloid leukemia; and ELVN-002, a central nervous system (CNS) penetrant and irreversible human epidermal growth factor receptor 2 inhibitor that is in Phase 1 clinical trial for the treatment of non-small cell lung cancer (NSCLC) and other HER2 mutant tumors. The company was founded in 2019 and is headquartered in Boulder, Colorado.
Organisation Biotechnology
Employees 60
Industry Biotechnology
CEO Mr. Richard A. Fair
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:
Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*
Take your next step
Enliven Therapeutics Inc FAQs
What is the share price of Enliven Therapeutics Inc today?
The current share price of Enliven Therapeutics Inc is $28.96.
Can I buy Enliven Therapeutics Inc shares in India?
Yes, Indian investors can buy Enliven Therapeutics Inc shares by opening an international trading and demat account with Motilal Oswal.
How to buy Enliven Therapeutics Inc shares in India?
You can easily invest in Enliven Therapeutics Inc shares from India by:
- Direct Investment:
Opening an international trading account with Motilal Oswal which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy Enliven Therapeutics Inc shares. - Indirect Investment:
Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of Enliven Therapeutics Inc.
Can I buy fractional shares of Enliven Therapeutics Inc?
Yes, many platforms allow you to buy fractional shares starting from as low as $1.
What is the market capitalization value of Enliven Therapeutics Inc?
Enliven Therapeutics Inc has a market cap of $1736.01 M.
In which sector does Enliven Therapeutics Inc belong?
Enliven Therapeutics Inc operates in the Biotechnology sector.
What documents are required to invest in Enliven Therapeutics Inc stocks?
To invest, you typically need:
What is the PE and PB ratio of Enliven Therapeutics Inc?
The PE ratio of Enliven Therapeutics Inc is N/A and the PB ratio is 3.91.